Showing 1 - 20 results of 40 for search 'Matthias Eiber', query time: 0.06s
Refine Results
-
1
PSMA-targeted imaging of prostate cancer: evolution of a success story by Tobias Maurer, Matthias Eiber
Published 2017-01-01
Article -
2
-
3
Influence of sampling schedules on [177Lu]Lu-PSMA dosimetry by Andreas Rinscheid, Peter Kletting, Matthias Eiber, Ambros J. Beer, Gerhard Glatting
Published 2020-06-01
Article -
4
Current status of PSMA-targeted imaging and therapy by Hui Wang, GuanNan Li, Jie Zhao, Jie Zhao, Matthias Eiber, Rong Tian
Published 2024-01-01
Article -
5
-
6
Current Staging Procedures in Urinary Bladder Cancer by Ambros J. Beer, Jürgen E. Gschwend, Matthias Eiber, Matthias Heck, Thomas Horn, Tobias Maurer
Published 2013-06-01
Article -
7
-
8
Pre-test 68Ga-PSMA-ligand PET/CT positivity in early biochemical recurrent prostate cancer after radical prostatectomy—validation of a prediction model by Pia Kraft, Tobias Maurer, Andrei Gafita, Markus Krönke, Bernhard Haller, Wolfgang A. Weber, Matthias Eiber, Isabel Rauscher
Published 2020-02-01
Article -
9
-
10
-
11
Synthesis and preclinical evaluation of novel 18F-labeled Glu-urea-Glu-based PSMA inhibitors for prostate cancer imaging: a comparison with 18F-DCFPyl and 18F-PSMA-1007 by Stephanie Robu, Alexander Schmidt, Matthias Eiber, Margret Schottelius, Thomas Günther, Behrooz Hooshyar Yousefi, Markus Schwaiger, Hans-Jürgen Wester
Published 2018-04-01
Article -
12
DosePatch: physics-inspired cropping layout for patch-based Monte Carlo simulations to provide fast and accurate internal dosimetry by Francesca De Benetti, Julia Brosch-Lenz, Jorge Mario Guerra González, Carlos Uribe, Matthias Eiber, Nassir Navab, Thomas Wendler
Published 2024-06-01
Article -
13
-
14
-
15
Matched-pair analysis of mCRPC patients receiving 177Lu-labeled PSMA-targeted radioligand therapy in a 4-week versus 6-week treatment interval by Amir Karimzadeh, Charlotte-Sophie Hecker, Matthias M. Heck, Robert Tauber, Calogero D’Alessandria, Wolfgang A. Weber, Matthias Eiber, Isabel Rauscher
Published 2024-10-01
Article -
16
-
17
Preclinical comparison of [177Lu]Lu-rhPSMA-10.1 and [177Lu]Lu-rhPSMA-10.2 for endoradiotherapy of prostate cancer: biodistribution and dosimetry studies by Alexander Wurzer, Francesco De Rose, Sebastian Fischer, Markus Schwaiger, Wolfgang Weber, Stephan Nekolla, Hans-Jürgen Wester, Matthias Eiber, Calogero D’Alessandria
Published 2024-02-01
Article -
18
Is there more than meets the eye in PSMA imaging in prostate cancer with PET/MRI? Looking closer at uptake time, correlation with PSA and Gleason score by Borjana Bogdanovic, Esteban L. Solari, Alberto Villagran Asiares, Sandra van Marwick, Sylvia Schachoff, Matthias Eiber, Wolfgang A. Weber, Stephan G. Nekolla
Published 2023-04-01
Article -
19
Automated synthesis of [18F]Ga-rhPSMA-7/ -7.3: results, quality control and experience from more than 200 routine productions by Alexander Wurzer, Daniel Di Carlo, Michael Herz, Antonia Richter, Stephanie Robu, Ralf Schirrmacher, Alba Mascarin, Wolfgang Weber, Matthias Eiber, Markus Schwaiger, Hans-Juergen Wester
Published 2021-01-01
Article -
20
A machine learning model for the prediction of survival and tumor subtype in pancreatic ductal adenocarcinoma from preoperative diffusion-weighted imaging by Georgios Kaissis, Sebastian Ziegelmayer, Fabian Lohöfer, Hana Algül, Matthias Eiber, Wilko Weichert, Roland Schmid, Helmut Friess, Ernst Rummeny, Donna Ankerst, Jens Siveke, Rickmer Braren
Published 2019-10-01
Article